Crossref
Cyclooxygenase-2 inhibitor rofecoxib prevents chondrocytes against hypertrophy via Wnt/β-catenin pathway.
JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS · 2020
DOI: 10.23812//20-78-a-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2020. Verfasst von Y.R. Yang.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Yang, Y. (2020). Cyclooxygenase-2 inhibitor rofecoxib prevents chondrocytes against hypertrophy via Wnt/β-catenin pathway. JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS. https://doi.org/10.23812//20-78-a-8
Vancouver
Yang Y. Cyclooxygenase-2 inhibitor rofecoxib prevents chondrocytes against hypertrophy via Wnt/β-catenin pathway. JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS. 2020. doi:10.23812//20-78-a-8
BibTeX
@article{Yang2020,
author = {Yang, Y.R.},
title = {Cyclooxygenase-2 inhibitor rofecoxib prevents chondrocytes against hypertrophy via Wnt/β-catenin pathway},
journal = {JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS},
year = {2020},
doi = {10.23812//20-78-a-8}
}
EUVIMED